Asthma associated with increased odds of venous thromboembolism, pulmonary embolism, and deep vein thrombosis in observational studies.
Asthma Linked to Higher Risk of Blood Clots in Observational Data
This meta-analysis of observational studies involving patients with asthma found a statistically significant association between asthma and …
People with asthma face a 1.61 times higher risk of blood clots, with the danger of pulmonary embolism rising 2.41 times and deep vein throm…
Regional anesthesia with propofol sedation versus general anesthesia in unilateral total knee arthroplasty patients.
Numb Legs, Faster Walks: New Knee Surgery Data
This retrospective cohort study evaluated 250 patients undergoing unilateral total knee arthroplasty to compare regional anesthesia with mon…
New knee surgery data shows regional anesthesia leads to faster walking and fewer readmissions without increasing dangerous blood clot risk.
Retrospective study reports 100% technical success for integrated IVC filter-thrombus retrieval technique
New technique successfully removes blood clot-filled IVC filters in small study
A single-center retrospective cohort of 51 patients with IVC filter thrombosis found the filter-thrombus integrated retrieval technique achi…
A new technique successfully removed blood clot-filled IVC filters in all 51 patients studied, with no serious complications and only minor,…
FDA Approves Xarelto (rivaroxaban) for multiple indications including stroke prevention in nonvalvular atrial fibrillation and treatment of VTE.
FDA approves a new blood thinner called Xarelto for several heart and clot conditions.
The FDA approved rivaroxaban (Xarelto), a factor Xa inhibitor, for multiple indications including reducing stroke risk in nonvalvular atrial…
FDA approves new blood thinner Xarelto to prevent dangerous clots in heart conditions, deep vein issues, and after major surgeries.
Home treatment for low-risk cancer-associated PE shows 4.6% major bleeding rate in ONCO PE companion report
Could some cancer patients safely treat blood clots at home? New research suggests yes.
A predetermined companion report from the ONCO PE trial evaluated 3-month outcomes for home vs. in-hospital treatment of active cancer patie…
Active cancer patients with low-risk lung clots can safely take blood thinners at home, avoiding disruptive hospital stays while staying on …